Longitudinal studies tracking CD8+ T cells, EBV load and MS-like symptoms in aging NHPs are needed to clarify this relationship and explore therapeutic strategies to enhance CD8+ T cell function in older patients. Here, CD8A is linked to myeloid sarcoma.